or
forgot password

    • cancer clinical trials in tennessee

    • Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Baptist Regional Cancer Center - Knoxville

    Trial Locations
    Baptist Regional Cancer Center - Knoxville
    West Clinic, P.C.
    Memphis Cancer Center
    Vanderbilt-Ingram Cancer Center
    St. Thomas Medical Center
    Colorectal Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Memphis

    Trial Locations
    Veterans Affairs Medical Center - Memphis
    University of Tennessee Cancer Institute - Memphis
    Vanderbilt-Ingram Cancer Center
    Lung Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    Vanderbilt-Ingram Cancer Center
    Head and Neck Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Memphis Cancer Center

    Trial Locations
    Memphis Cancer Center
    West Clinic
    Vanderbilt-Ingram Cancer Center
    Tennessee Oncology, P.L.L.C.
    Colorectal Cancer
    Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
    West Clinic, P.C.
    Memphis, Tennessee 38117
    Multiple Myeloma and Plasma Cell Neoplasm
    Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group
    Memphis, Tennessee 38119
    Pancreatic Cancer
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    East Tennessee Oncology/Hematology, P.C.

    Trial Locations
    East Tennessee Oncology/Hematology, P.C.
    West Clinic
    Breast Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    St. Jude Children's Research Hospital

    Trial Locations
    St. Jude Children's Research Hospital
    Vanderbilt University
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Memphis, Tennessee 38104
    Prostate Cancer
    Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
    Knoxville Dermatology Group, P.C.
    Knoxville, Tennessee 37920
    Lymphoma
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Erlanger Cancer Center

    Trial Locations
    Erlanger Cancer Center
    Veterans Affairs Medical Center - Memphis
    Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
    Prostate Cancer
    Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus
    Multiple Myeloma and Plasma Cell Neoplasm
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Thompson Cancer Survival Center

    Trial Locations
    Thompson Cancer Survival Center
    Baptist Memorial Hospital - Memphis
    Meharry Medical College
    Methodist Regional Cancer Center
    Alzheimer Disease
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    MBCCOP - Meharry Medical College - Nashville

    Trial Locations
    MBCCOP - Meharry Medical College - Nashville
    Nashville Oncology Associates, PC
    Breast Cancer
    Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Graft Versus Host Disease
    ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
    University Oncology/ Hematology Associates

    Trial Locations
    University Oncology/ Hematology Associates
    Boston Baskin Cancer Group
    Prostate Cancer
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    University of Tennessee - Graduate School of Medicine

    Trial Locations
    University of Tennessee - Graduate School of Medicine
    Urology Associates
    Prostate Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia
    A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
    Knoxville Neurology Associates, Baptist Hospital
    Knoxville, Tennessee 37920
    Multiple Sclerosis, Relapsing-Remitting
    Vaccine Therapy for Patients With Stage III Melanoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Malignant Melanoma
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Blue Ridge Medical Specialists, PC

    Trial Locations
    Blue Ridge Medical Specialists, PC
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Thompson Cancer Survival Center
    Esophageal Cancer, Gastric Cancer